Blog - Page 4229 of 5516

WednesdayOct 22, 2008 4:58 pm

The Fight Zone, Inc. (TFZI.PK): An Investment Opportunity in the Mixed Martial Arts World

The Fight Zone, Inc. (TFZI.PK) is dedicated to developing and promoting the mixed martial arts (MMA) world and their athletes. The company's core focus is set on developing and producing only world-class fighters. The Fight Zone provides complete services including discipline training, strength and conditioning training, management, marketing and sponsorship programs. Mixed martial arts, known mainly as MMA, is a full contact combat sport in which the participants draw from a variety of fighting disciplines including jiu-jitsu, karate, wrestling, boxing, and many others, in order to submit or knockout their opponent. There is no doubt that MMA is easily the…

WednesdayOct 22, 2008 1:15 pm

Tri-Star Holdings, Inc. (TSHL.PK) Divests Amore TV, Appoints Three New Officers

Today, Tri-Star Holdings announced that it has divested Amore TV as part of its corporate restructuring strategy and vision of future growth. By divesting Amore TV, the company has eliminated liabilities and made it possible to focus more attention to its diversifying metals industry division. Tri-Star Holdings believes this move is in the best interest of the company’s progress and shareholder value. Also announced was the appointment of three new officers. These officers were appointed by the company’s board of directors. J. Rocky Hollingshead was appointed to the office of COO, Charles L. Ilvento was appointed CFO, and Scott Spooner…

WednesdayOct 22, 2008 12:44 pm

FDA Approves the Endologix, Inc. (ELGX) IntuiTrak™ Delivery System

Abdominal Aortic Aneurysms (AAA) is an aneurysm caused from a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a leading cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA. The overall patient mortality rate for ruptured AAA is approximately 75%. IntuiTrak has a novel design and deployment mechanism that simplifies delivery of the unibody bifurcated Powerlink device. The low-profile delivery system features enhanced flexibility,…

WednesdayOct 22, 2008 12:42 pm

Elray Resources, Inc. (ELRA.OB) – Diving into the Zircon Sands of Indonesia

Founded by senior executives and geologists with experience in the major gold production companies, Elray Resources saw a niche for a company that could combine the level of expertise typically found in a major company with the responsiveness, speed and growth potential of a junior firm. It’s this quick, nimble movement of Elray Resources that has led them to the latest in mineral finds – the Indonesian Zircon Sands. Indonesia has some of the world's largest deposits of zircon sand, coal, copper, tin, nickel and gold, and is keen to earn more from the sector particularly as strong demand from…

WednesdayOct 22, 2008 12:40 pm

China Water and Drinks, Inc. (CWDK.OB) and Heckmann Corporation (HEK) Close Acquisitions

Bottled water continues to be a huge market worldwide. Back in May, China Water entered into a definitive merger agreement with Heckmann Corporation. Closing of the merger is expected to occur on October 31st, pending shareholder approval. The joining of the two water giants is expected to continue the financial flexibility of the conglomerate, with the acquisitions of two multi-million dollar bottled water companies as proof of their new purchasing power. U.S. sales of bottled water rose by nearly 10 percent in 2006, according to estimates from Beverage Marketing Corporation provided to the International Bottled Water Association. Americans consumed about…

WednesdayOct 22, 2008 12:13 pm

RXi Pharmaceuticals (RXII) Hires Dr. Anastasia Khvorova as its First Chief Scientific Officer

RXi Pharmaceuticals Corporation (NASDAQ: RXII) reported today that it has hired Dr. Anastasia Khvorova to fill the new post of Chief Scientific Officer (CSO). RXi Pharmaceuticals expects to benefit from the six years of experience Khvorova gained in the development and supply of RNAi compounds in her last job as CSO of Dharmacon, Inc. According to company President and CEO, Dr. Tod Woolf, Khvorova’s appointment adds to the scope and depth of RXi’s talent in the RNAi field. "Among her many accomplishments,” noted Woolf, “Dr. Khvorova's group at Dharmacon designed and manufactured RNAi compounds targeting virtually all of the known…

WednesdayOct 22, 2008 11:54 am

Kidney Cancer May Meet its Match with Antigenics Inc.’s (AGEN) Marketing Application Submittal

Renal Cell Carcinoma is the most common type of kidney cancer. According to the International Agency for Research on Cancer, renal cell carcinoma accounts for nearly 90 percent of all kidney tumors. Approximately 60,511 new cases of kidney cancer were diagnosed in 2004, 29,453 of those individuals diagnosed died from the disease. Antigenics Inc.’s (Nasdaq: AGEN) Oncophage contains an “antigenic fingerprint” of a patient’s particular cancer. It was designed to reprogram the body’s immune system to target only the cancer cells with this specific fingerprint. In April, 2008, Oncophage was approved in Russia for the treatment of kidney cancer patients;…

WednesdayOct 22, 2008 11:37 am

Monogram Biosciences, Inc. (MGRM) Presents Its VeraTagTM Assays at EORTC-NCI-AACR Symposium

Monogram Biosciences, Inc., a California based leader in molecular diagnostics for improving drug treatment of serious diseases, today announced presentations made by its scientists related to the company’s VeraTag™ assays. The presentations were made at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Geneva, Switzerland. The presentations dealt with what are called EGFR/HER receptors, known to be significant to the proliferation of many different cancers, such as breast cancer. The presentations were about Monogram’s developments in the field of assays used for detecting these receptors in cancerous tissues, information that is critical for associated drug development and…

WednesdayOct 22, 2008 11:35 am

Dyax Corp. (DYAX) Announces Major Third Quarter Revenue Increase

Dyax Corporation, a Massachusetts biopharmaceutical company, has announced third quarter revenues of $5.5 million, compared with $2.6 million for the comparable quarter in 2007, an increase of 111%. In addition, revenues for the nine-month period ending September 30, 2008, increased to $12.0 million, compared to $7.9 million for the comparable nine-month period in 2007, an increase of nearly 52%. The dramatic increase in revenue was due largely to returns from license and collaboration agreements, including $2.5 million received under the company’s Licensing & Funded Research Program (LFRP). Dyax has also received $38.2 million from licensing and collaboration agreements for its…

WednesdayOct 22, 2008 11:35 am

Liquor Group Wholesale and Southern Wine & Spirits Enter a Working Relationship

Florida based publicly owned specialty spirits and wine distributor Liquor Group Wholesale Inc. (LIQR) has entered a working partnership with Southern Wine & Spirits of America in the western liquor control states. With operations in 31 states, Liquor Group Wholesale distributes more than 1700 products including brands such as Happy Vodka, Trump Super Premium Vodka, Pendleton’s Canadian Whisky, Damiana, Willie Nelson’s Old Whiskey River Bourbon to name just a few in the 18 National Alcohol Beverage Control States of America (NABCA). “We have been looking closely at the performance of brokerage operations in control states with boots on the ground…

Site Search

Company Search